A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The transforming genes of oncogenic retroviruses are homologous to a group of evolutionary conserved cellular onc genes. The human cellular homologue (c-abl) of the transforming sequence of Abelson murine leukaemia virus (A-MuL V) was recently shown to be located on chromosome 9. The long arm of this chromosome is involved in a specific translocation with chromosome 22, the Philadelphia translocation (Ph1), t(9; 22) (q34, q11), which occurs in patients with chronic myelocytic leukaemia (CML)3-5. Here we investigate whether the c-abl gene is included in this translocation. Using c-abl and v-abl hybridization probes on blots of somatic cell hybrids, positive hybridization is found when the 22q- (the Philadelphia chromosome), and not the 9q+ derivative of the translocation, is present in the cell hybrids. From this we conclude that in CML, c-abl sequences are translocated from chromosome 9 to chromosome 22q-. This finding is a direct demonstration of a reciprocal exchange between the two chromosomes and suggests a role for the c-abl gene in the generation of CML.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The importance of proto-oncogenes was further highlighted by discoveries that nonviral cancers frequently have genetic alterations in proto-oncogenes that activate them and drive oncogenesis—for example, mutations in H-ras or K-ras (76), gene amplification of c-myc (77), and chromosomal translocation/activation involving c-abl (78).”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [78]
Citations
Cites
ROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene
Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 944
Der, C. J., Krontiris, T. G., & Cooper, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3637 · Cited by 800
A physical map of the DNA regions flanking the rabbit β-globin gene
Jeffreys, A. (1977) · Cell · doi:10.1016/0092-8674(77)90119-2 · Cited by 644
Santos, E., Tronick, S. R., Aaronson, S. A., Pulciani, S., & Barbacid, M. (1982) · Nature · doi:10.1038/298343a0 · Cited by 623
Chang, E. H., Furth, M. E., Scolnick, E. M., & Lowy, D. R. (1982) · Nature · doi:10.1038/297479a0 · Cited by 587
Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosine
Witte, O. N., Dasgupta, A., & Baltimore, D. (1980) · Nature · doi:10.1038/283826a0 · Cited by 530
Goff, S. P., Gilboa, E., Witte, O. N., & Baltimore, D. (1980) · Cell · doi:10.1016/0092-8674(80)90554-1 · Cited by 470
Khan, P. M. (1971) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(71)80007-3 · Cited by 344
Chromosomal localization of human cellular homologues of two viral oncogenes
Heisterkamp, N., Groffen, J., Stephenson, J. R., Spurr, N. K., Goodfellow, P. N., Solomon, E., Carritt, B., & Bodmer, W. F. (1982) · Nature · doi:10.1038/299747a0 · Cited by 303
Self-citation
Research works printed but not linked: 2
- Heisterkamp, N., Groffen, J. & Stephenson, J. R. J. molec. appl. Genet. (in the press).
- Ferguson-Smith, M. A. & Aitken, D. A. Cytogenet. Cell Genet. 22, 49–451 (1978).
Cited by
Items 801–900 of 1,000
Simanovsky, M., Berlinsky, S., Sinai, P., Leiba, M., Nagler, A., & Galski, H. (2008) · Differentiation · doi:10.1111/j.1432-0436.2008.00270.x · Cited by 11
Marcé, S., Zamora, L., Cabezón, M., Xicoy, B., Boqué, C., Fernández, C., Grau, J., Navarro, J., de Sevilla, A. F., Ribera, J., et al. (2013) · Medicina Clínica · doi:10.1016/j.medcli.2012.10.028 · Cited by 11
Review: Molecular analysis of the Philadelphia chromosome
Dobrovic, A., Peters, G. B., & Ford, J. H. (1991) · Chromosoma · doi:10.1007/bf00352198 · Cited by 11
Druker, B. J. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-963-9_81 · Cited by 11
Contribution of immunophenotypic and genotypic analyses to the diagnosis of acute leukemia
Stasi, R., Taylor, C. G., Venditti, A., Poeta, G. D., Aronica, G., Bastianelli, C., Simone, M. D., Buccisano, F., Cox, M. C., Bruno, A., et al. (1995) · Annals of Hematology · doi:10.1007/bf01696228 · Cited by 17
Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia: When Should It Be Used?
Mauro, M. J., & Maziarz, R. T. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.3.404 · Cited by 11
Role of the abl Oncogene in Chronic Myelogenous Leukemia
Mes‐Masson, A., & Witte, O. N. (1987) · Advances in cancer research · doi:10.1016/s0065-230x(08)60794-0 · Cited by 11
Rearrangement of the human ABL oncogene in a glioblastoma.
Heisterkamp, N., Morris, C. M., Sender, L., Knoppel, E., Uribe, L., Cui, M. Y., & Groffen, J. (1990) · PubMed · Cited by 11
Self-citationOncogenes: Clues to carcinogenesis
Bartram, C. (1984) · European Journal of Pediatrics · doi:10.1007/bf00443210 · Cited by 11
Self-citationBE‐23372M, a Novel and Specific Inhibitor for Epidermal Growth Factor Receptor Kinase
Tanaka, S., Okabe, T., Chieda, S., Endo, K., Kanoh, T., Okura, A., & Yoshida, E. (1994) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1994.tb02090.x · Cited by 11
Activation of proto-oncogenes in human leukemias
Bartram, C. (1985) · Annals of Hematology · doi:10.1007/bf00320114 · Cited by 11
“Actually, a consistent transfer of c-abl from chromosome 9 to Ph 1 in all cytogenetic subtypes of phi-positive CML could be demonstrated [1, 13, 22, 23].”
BackgroundSelf-citationStuart, R. K., & Mangan, K. F. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90728-x · Cited by 11
Chronic Myelocytic (Multipotent-Stem-Cell) Leukemia
Kersey, J. H. (1983) · New England Journal of Medicine · doi:10.1056/nejm198310063091409 · Cited by 11
Goyns, M. H., Young, B. D., van Kessel, A. G., de Klein, A., Grosveld, G. C., Bartram, C., & Bootsma, D. (1984) · Leukemia Research · doi:10.1016/0145-2126(84)90003-1 · Cited by 11
Self-citationExpression profiling across many samples via manifold-assisted mRNA processing
Hagberg, A. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.11.e54 · Cited by 11
Büküm, N., Novotná, E., Morell, A., Želazková, J., Laštovičková, L., Čermáková, L., Portillo, R., Solich, P., & Wsól, V. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114710 · Cited by 12
Predicting the response of CML patients to tyrosine kinase inhibitor therapy
White, D. L., & Hughes, T. P. (2009) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-009-0009-2 · Cited by 10
de Oliveira, F. M., Jamur, V. R., Merfort, L. W., Pozzo, A. R., & Mai, S. (2022) · BMC Cancer · doi:10.1186/s12885-022-10094-5 · Cited by 10
“Is there an entity of chemically induced BCR-ABL-positive chronic myelogenous leukemia?”
BackgroundInfluentialHochhaus, A., Mahon, F., le Coutre, P., Petrov, L., Janssen, J. J. W. M., Cross, N. C. P., Réa, D., Castagnetti, F., Hellmann, A. R., Rosti, G., et al. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2359-9 · Cited by 10
Kakadia, P. M., de Water, N. V., Browett, P., & Bohlander, S. K. (2018) · Scientific Reports · doi:10.1038/s41598-018-31503-5 · Cited by 10
Chromosomal Localization of Protooncogenes
Tereba, A. (1985) · International review of cytology · doi:10.1016/s0074-7696(08)60577-x · Cited by 10
Pipkorn, R., Waldeck, W., & Braun, K. (2003) · Journal of Molecular Recognition · doi:10.1002/jmr.632 · Cited by 10
p53 Alterations in Myeloid Leukemia
Boyapati, A., Kanbe, E., & Zhang, D. (2003) · Acta Haematologica · doi:10.1159/000074489 · Cited by 10
César, J. M., Cabello, P., Ferró, T., & Navarro, J. L. (2006) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2005.10.005 · Cited by 10
Okuda, K., D’Andrea, A. D., Etten, R. A. V., & Griffin, J. D. (1998) · Blood · doi:10.1182/blood.v92.10.3848 · Cited by 10
Chromosomal translocations in two feline T-cell lymphomas
Wu, F.-Y., Iijima, K., Tsujimoto, H., Tamura, Y., & Higurashi, M. (1995) · Leukemia Research · doi:10.1016/0145-2126(95)00073-9 · Cited by 10
Unusual Ph translocations in the French prospective study on chronic myeloid leukemia
GROUPEFRANCAISDECYTOGENETIQUE (1985) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(85)90238-9 · Cited by 10
Andrews, D. F., Nemunaitis, J. J., & Singer, J. W. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6788 · Cited by 10
Expression of the c‐fgr related transcripts in epstein‐barr virus‐associated malignancies
Klein, C., Busson, P., Tursz, T., Young, L. S., & Raab‐Traub, N. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910420107 · Cited by 10
“For example, in human malignancies the structure and expression of the oncogenes c-myc in Burkitt’s lymphoma (BL) (Dalla-Favera et al., 1982) and c-abl in chronic myelogeneous leukemia (De Klein et al., 1982; Rowley, 1973) are modified by chromosomal translocation.”
BackgroundThe Molecular Biology of Radiation Carcinogenesis
Hall, E. J., & Freyer, G. A. (1991) · Springer eBooks · doi:10.1007/978-1-4684-7627-9_1 · Cited by 10
Valent, P., Lion, T., Wolf, D. G. F., Sillaber, C., Agis, H., Petzer, A. L., Lang, A. H., Kalhs, P., Geissler, D., Greil, R., et al. (2008) · Wiener klinische Wochenschrift · doi:10.1007/s00508-008-1100-8 · Cited by 11
Oncogenes: Molecular probes for clinical application in malignant diseases
Ascione, R., Sacchi, N., Watson, D. K., Fisher, R. J., Fujiwara, S., Seth, A. K., & Papas, T. S. (1986) · Gene Analysis Techniques · doi:10.1016/0735-0651(86)90020-8 · Cited by 10
Hittelman, W. N., & Preisler, H. D. (1986) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(86)80020-8 · Cited by 10
Genomic Analyses Using Fluorescence in Situ Hybridization
Guo, X., Wang, Y., & Xu, Z. (2007) · Wiley eBooks · doi:10.1002/9780470277560.ch17 · Cited by 10
Bicknell, D., Markie, D., Spurr, N. K., & Bodmer, W. F. (1991) · Genomics · doi:10.1016/0888-7543(91)90499-5 · Cited by 10
Self-citationWirschubsky, Z. G., Perlmann, C., Lindsten, J., & Klein, G. (1983) · International Journal of Cancer · doi:10.1002/ijc.2910320203 · Cited by 10
Chromosomal rearrangements in bladder cancer
Gibas, Z., & Sandberg, A. A. (1984) · Urology · doi:10.1016/s0090-4295(84)80107-7 · Cited by 10
Ohyashiki, J. H., Ohyashiki, K., Kinniburgh, A. J., Raza, A., Preisler, H. D., & Sandberg, A. A. (1987) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(87)90154-3 · Cited by 10
Molecular Biology of the Type 1 IGF Receptor
Werner, H. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-712-3_4 · Cited by 10
Mitra, A., Sasikumar, K., Parthasaradhi, B. V. V., & Radha, V. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.10.014 · Cited by 9
Selective and sensitive detection of chronic myeloid leukemia using fluorogenic DNAzyme probes
Geng, X., Zhang, M., Wang, X., Sun, J., Zhao, X., Zhang, L., Wang, X., & Shen, Z. (2020) · Analytica Chimica Acta · doi:10.1016/j.aca.2020.04.069 · Cited by 9
Kaur, P., & Khan, W. A. (2022) · Exon Publications eBooks · doi:10.36255/exon-publications-leukemia-pdgfra-rearrangement · Cited by 9
Strategies in functional proteomics: Unveiling the pathways to precision oncology
Favicchio, R., Thepaut, C., Zhang, H., Arends, R., Stebbing, J., & Giamas, G. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.049 · Cited by 10
Making the diagnosis, the tools, and risk stratification: More than just BCR-ABL
Egan, D. N., & Radich, J. P. (2016) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2016.10.015 · Cited by 9
Genetic Alterations in Human Tumors
Cho, K. R., & Hedrick, L. (1997) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-60505-5_7 · Cited by 9
Rosendorff, J., Bowcock, A. M., Kuyl, J. M., Mendelow, B., Pinto, M. R., & Bernstein, R. (1987) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(87)90090-2 · Cited by 9
Human genetics: Human gene mapping rolls along
Solomon, E., & Goodfellow, P. N. (1983) · Nature · doi:10.1038/306223b0 · Cited by 9
Exon-skipping in BCR/ABL is induced by ABL exon 2
Lichty, B. D., & Kamel‐Reid, S. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3480063 · Cited by 9
Peters, J. A. (1997) · Seminars in Oncology Nursing · doi:10.1016/s0749-2081(97)80003-4 · Cited by 9
BCR-ABL Rearrangement in Adult T-cell Acute Lymphoblastic Leukemia
Colleoni, G. W. B., Yamamoto, M., Kerbauy, J., Serafim, R. C., Lindsey, C. J., Costa, F. F., Grignoli, C. R. E., & Saad, S. (1996) · American Journal of Hematology · doi:10.1002/1096-8652(199612)53:4 · Cited by 9
RNA-tumoriviruses, oncogenes, and their possible role in human carcinogenesis
Hehlmann, R., Schetters, H., Kreeb, G., Erfle, V., Schmidt, J., & Luz, A. (1983) · Journal of Molecular Medicine · doi:10.1007/bf01540470 · Cited by 9
Complex Karyotype with PH1Chromosome in Myelodysplasia: Cytogenetic and Molecular Studies
Larripa, I. B., Gutiérrez, M. I., Giere, I. A., Acevedo, S., Bengio, R. M. N., & Slavutsky, I. R. (1992) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199209053573 · Cited by 9
HIV/AIDS in the Caribbean. The need for a more effective public health response.
Jp, F. (2003) · PubMed · Cited by 9
Oncogenes modulate cell sensitivity to apoptosis induced by glucose deprivation.
Kansara, M., & Berridge, M. V. (2004) · PubMed · Cited by 9
Perucho, M. (1994) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-0257-8_31 · Cited by 9
Tefferi, A. (2007) · Springer eBooks · doi:10.1007/978-3-540-34506-0_18 · Cited by 9
The ABL oncogene in human leukemias
Westbrook, C. A. (1988) · Blood Reviews · doi:10.1016/0268-960x(88)90002-1 · Cited by 9
Approaches to proto-oncogene and tumour suppressor gene identification
Patterson, H. (1992) · European Journal of Cancer · doi:10.1016/0959-8049(92)90428-5 · Cited by 9
A case of M2 acute myeloblastic leukemia associated with an interstitial 9q deletion
Lin, C. C., Braekeleer, M. D., Etches, W. S., & Thay, T. Y. (1987) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(87)90095-1 · Cited by 9
Isolation and Characterization of DNA Sequences from Flow-Sorted Human Chromosome 22 Libraries
Metzdorf, R., Herzog, R. M., tten, E. G. O., & Blin, N. (1990) · Human Heredity · doi:10.1159/000153922 · Cited by 9
Patterson, B. K., Mosiman, V. L., Cantarero, L., Furtado, M. R., Bhattacharya, M., & Goolsby, C. L. (1998) · Cytometry · doi:10.1002/(sici)1097-0320(19980401)31:4<287::aid-cyto8>3.0.co;2-g · Cited by 40
Blick, M. B., Andersson, B. S., Gutterman, J. U., Keating, A., & Beran, M. (1986) · Leukemia Research · doi:10.1016/0145-2126(86)90006-8 · Cited by 9
Denman, A. M. (1984) · Clinics in Rheumatic Diseases · doi:10.1016/s0307-742x(21)00481-1 · Cited by 9
Barachini, S., Montali, M., Burzi, I. S., Pardini, E., Infirri, G. S., Cassano, R. C., & Petrini, I. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.105090 · Cited by 10
Somatic Engineering of Oncogenic Chromosomal Rearrangements: A Perspective
Maddalo, D., & Ventura, A. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0726 · Cited by 8
“This idea, initially met with skepticism, was finally proven correct nearly 50 years later with the identification of the "Philadelphia Chromosome" (2), a reciprocal translocation involving chromosomes 9 and 22 (3) that leads to the formation of an oncogenic gene fusion between BCR and ABL1 (4, 5).”
Zhang, W., Kuang, P., & Liu, T. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243657 · Cited by 11
“This translocation joins almost the entire coding region of the ABL1 (Abelson murine leukemia viral oncogene homolog 1) tyrosine kinase gene on chromosome 9 to the breakpoint cluster region (BCR) gene on chromosome 22, generating the BCR-ABL1 fusion gene [11].”
BackgroundVysochinskaya, V. V., Dovbysh, O. V., Gorshkov, A. N., Brodskaia, A. V., Dubina, M., Vasin, A. V., & Zabrodskaya, Y. A. (2024) · Biomolecules · doi:10.3390/biom14060644 · Cited by 8
“The constitutive tyrosine kinase activity of this protein is responsible in the malignant transformation of bone marrow stem cells, driving the pathogenesis of CML [3–6].”
BackgroundGiallongo, C., Cava, P. L., Tibullo, D., Parrinello, N. L., Barbagallo, I. A., Fabro, V. D., Stagno, F., Conticello, C., Romano, A., Chiarenza, A., et al. (2011) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2010.01570.x · Cited by 8
Antioxidant agents transiently inhibit aneuploidy progression in Li‐Fraumeni cell strains
Kraniak, J. M., Abrams, J., Nowak, J. E., & Tainsky, M. A. (2005) · Molecular Carcinogenesis · doi:10.1002/mc.20145 · Cited by 8
“This and other neoplastic traits are preceded bynumerical or structural chromosomal abnormalities that may provide a mutational mechanism [73,74].”
BackgroundHecht, F., Morgan, R., Schrier, S. L., Adams, J. W., & Sandberg, A. A. (1985) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(85)90209-2 · Cited by 8
Chronic myelogenous leukemia with t(9;22) and t(8;11): A new chromosome anomaly
Laı̈, J. L., Jouet, J. P., Savary, J. B., Fenaux, P., Bauters, F., & Deminatti, M. (1987) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(87)90165-8 · Cited by 8
Zitzelsberger, H. F., Bauchinger, M., Wilmanns, W., & Strauss, P. G. (1990) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(90)90031-5 · Cited by 8
Chronic Myeloid Leukemia with a Rare Variant Philadelphia Translocation
Guillaume, B., Ameye, G., Libouton, J., Dierlamm, J., Vaerman, J.-L., Straetmans, N., Ferrant, A., Verellen‐Dumoulin, C., & Michaux, L. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(99)00115-6 · Cited by 8
Ray, F. A. (1995) · Infectious agents and pathogenesis · doi:10.1007/978-1-4899-1100-1_2 · Cited by 8
Oudat, R., Khan, Z., & Glassman, A. B. (2001) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2001-125-0437-aucvpc · Cited by 8
Antisense inhibition of P210bcr‐ablin chronic myeloid leukemia
Vaerman, J. L., Lewalle, P., & Martiat, P. (1993) · Stem Cells · doi:10.1002/stem.5530110921 · Cited by 8
van Kessel, A. G., Nusse, R., Slater, R. M., Tetteroo, P. A. T., & Hagemeijer, A. (1985) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(85)90132-3 · Cited by 8
Self-citationCytogenetic changes at 11q11, 11q23, and 17q11 in myelodysplastic syndrome
Ohyashiki, K., Yoshida, M. A., Gibas, L. M., Ohyashiki, J. H., Katsunuma, H., Ryan, D. H., Rowe, J. M., & Sandberg, A. A. (1986) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(86)90207-4 · Cited by 8
Chronic myeloid leukemia with a Philadelphia chromosome involving a t(21;22)
Pinkerton, P. H., London, B., & Senn, J. S. (1984) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(84)90131-6 · Cited by 8
Involvement of chromosomal region 9q34 in a case of variant Ph1 translocation t(22;22)
Mareni, C., Sessarego, M., Coviello, D. A., Origone, P., & Ajmar, F. (1986) · Leukemia Research · doi:10.1016/0145-2126(86)90058-5 · Cited by 8
Breakpoint distribution in variant Philadelphia translocations in chronic myeloid leukemia
Braekeleer, M. D. (1986) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(86)90414-0 · Cited by 8
Fioretos, T., & Johansson, B. (2010) · Wiley eBooks · doi:10.1002/9781118010136.ch7 · Cited by 11
Malignant transformation by abl and BCR/ABL
Etten, R. A. V. (1993) · Cancer treatment and research · doi:10.1007/978-1-4615-3088-6_8 · Cited by 8
New variant Ph translocation in chronic myeloid leukemia: t(Y;22)(p11;q11)
Gallego, M. S., Baialardo, E. M., Gutierrez, M., Bonduel, M., & Feliu, A. (1996) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(95)00231-6 · Cited by 7
Swaroop (2009) · Annual Review of Genomics and Human Genetics · doi:10.1146/genom.2009.10.issue-1 · Cited by 7
Geographic/ethnic variability of chromosomal and molecular abnormalities in leukemia
Braekeleer, M. D., Braekeleer, E. D., & Douet‐Guilbert, N. (2015) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2015.1068123 · Cited by 9
“Distribution of BCR-ABL1 in chronic myeloid leukemia CML is characterized by the t(9;22)(q34;q11) leading to the fusion of BCR on chromosome 22 and ABL1 (ABL protooncogene 1) on chromosome 9 [25].”
BackgroundHaus, O., Noworolska, A., Laskowski, M., Kuliszkiewicz-Janus, M., Kozłowska, J., Harłoziñska-Szmyrka, A., Jagielski, J., & Kotlarek-Haus, S. (1990) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(90)90008-2 · Cited by 7
A chimeric receptor/oncogene that can be regulated by a ligand in vitro and in vivo.
Okuda, K., D’Andrea, A. D., Etten, R. A. V., & Griffin, J. D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119695 · Cited by 7
A Model of Oscillatory Blood Cell Counts in Chronic Myelogenous Leukaemia
Drobnjak, I., & Fowler, A. C. (2011) · Bulletin of Mathematical Biology · doi:10.1007/s11538-011-9656-2 · Cited by 7
Newman-Smith, E. D., Shurland, D., & van der Bliek, A. M. (1997) · Genomics · doi:10.1006/geno.1996.4596 · Cited by 7
Development of a protease-resistant reporter to quantify BCR–ABL activity in intact cells
Proctor, A., Zigoneanu, I. G., Wang, Q., Sims, C. E., Lawrence, D. S., & Allbritton, N. L. (2016) · The Analyst · doi:10.1039/c6an01378c · Cited by 7
Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario
Cândido, M. F., Medeiros, M., Veronez, L. C., Bastos, D., Oliveira, K. L., Pezuk, J. A., Valera, E. T., & Brassesco, M. S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020664 · Cited by 8
Léglise, M.-C., Pluchon-riviére, E., Calvez, G. L., Abgrall, J. F., Berthou, C., Autrand, C., Sensebé, L., Balcon, D., & Roux, A.-M. L. (1996) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199209067600 · Cited by 7
Managing cancer during pregnancy: what evidence do we have?
Azim, H. A., & Peccatori, F. A. (2011) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.1015 · Cited by 7
Molecular evidence for the clonal origin of blast crisis in chronic myeloid leukaemia
Zalcberg, J. R., Friedlander, M. L., & Minden, M. D. (1986) · British Journal of Cancer · doi:10.1038/bjc.1986.73 · Cited by 7
Localization of the retinoid X receptor alpha gene (RXRA) to chromosome 9q34
Jones, K. A., Fitzgibbon, J., Woodward, K. J., Goudie, D. R., FERGUSON‐SMITH, M. A., Povey, S., Wolfe, J., & Solomon, E. (1993) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1993.tb01595.x · Cited by 7
Target Acquired: Progress and Promise of Targeted Therapeutics in the Treatment of Prostate Cancer
Stuchbery, R., Kurganovs, N. J., McCoy, P. J., Nelson, C. C., Hayes, V. M., Corcoran, N. M., & Hovens, C. M. (2015) · Current Cancer Drug Targets · doi:10.2174/1568009615666150416113453 · Cited by 7
Down-Modulation of P210 bcr/abl Induces Apoptosis/Differentiation in K562 Leukemic Blast Cells
Deora, A. B., Miranda, M. B., & Rao, S. G. A. (1997) · Tumori Journal · doi:10.1177/030089169708300409 · Cited by 7
From xeroderma pigmentosum to the biological clock contributions of Dirk Bootsma to human genetics
Hoeijmakers, J. H. J. (2001) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(00)00079-3 · Cited by 13
Guinn, B., Evely, R. S., Walsh, V., Gilkes, A., Burnett, A. K., & Mills, K. (2000) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190009089440 · Cited by 7
Metadata
- Authors
- Klein, A. D., Kessel, A. G. V., Grosveld, G., Bartram, C. R., Hagemeijer, A., Bootsma, D., Spurr, N. K., Heisterkamp, N., Groffen, J., & Stephenson, J. R.
- Affiliations
- Erasmus University Rotterdam (NL)
- National Cancer Institute (US)
- Venue
- Nature
- Published
- 1982-12
- Volume
- 300
- Issue
- 5894
- Pages
- 765-767
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2060833726
- Cited by
- 1,378
- References
- 27
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 17 · 2023: 12 · 2022: 25 · 2021: 17 · 2020: 18 · 2019: 15 · 2018: 23 · 2017: 28 · 2016: 24 · 2015: 33 · 2014: 16 · 2013: 26 · 2012: 33
- FWCI
- 50.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- Philadelphia chromosome, chromosome 9, chromosome 22, reciprocal translocation, cellular oncogenes, somatic cell hybrids
- MeSH terms
- Chromosomes, Human, 21-22 and Y, Chromosomes, Human, 6-12 and X, DNA, Neoplasm, Gene Expression Regulation, Humans, Leukemia, Myeloid, Oncogenes, Translocation, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.